EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A modified CD9 tag for efficient protein delivery via extracellular vesicles

Shojiro Inano iD, Toshiyuki Kitano

PLOS ONE · 17.10.2024 · 19 (10) · e0310083

DOI: 10.1371/journal.pone.0310083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 17.10.2024. Verfasst von Shojiro Inano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Kitano Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Tetraspanin 29, Extracellular Vesicles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are attracting growing attention for therapeutic use and as diagnostic markers, particularly for cancer. Although therapies based on small interfering RNAs are under intensive research, other therapeutic molecules, especially proteins, have not been sufficiently investigated. One of the major method for loading proteins into EVs is electroporation; however, it damages membrane integrity and requires repeated purification, precluding clinical applications. Thus, natural and efficient protein transfer is a prerequisite for the clinical application of protein-based EV therapy. Another prerequisite is an efficient endosomal escape, as most EVs incorporated into receptor cells result in endosomal degradation. Therefore, we generated a short CD9 (sCD9)-INF/TAT tag for efficiently transfers fused proteins to the EV and enhances endosomal escape to address the abovementioned problems. Interestingly, protein transfer via EVs drastically improved when the EV producer and receptor cells were cocultured, strongly indicating bystander effects of cells producing therapeutic proteins fused with a sCD9-INF/TAT tag. This method can be applied to a wide range of therapeutic technologies, including cellular transplantation or viral therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tetraspanin 29Extracellular VesiclesHumansProtein TransportRecombinant Fusion ProteinsEndosomesHEK293 Cells

Substanzen

Tetraspanin 29CD9 protein, humanRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Hematology, Kitano Hospital, Osaka, Japan.
  • Kansai Electric Power Medical Research Institute, Osaka, Japan.
  • Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT), Kyoto University Hospital, Kyoto, Japan.

ORCID-Profile: Shojiro Inano

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Inano, S., & Kitano, T. (2024). A modified CD9 tag for efficient protein delivery via extracellular vesicles. PLOS ONE, 19(10), e0310083. https://doi.org/10.1371/journal.pone.0310083

Vancouver

Inano S, Kitano T. A modified CD9 tag for efficient protein delivery via extracellular vesicles. PLOS ONE. 2024;19(10):e0310083. doi:10.1371/journal.pone.0310083

BibTeX
@article{Inano2024,
  author = {Inano, Shojiro and Kitano, Toshiyuki},
  title = {A modified CD9 tag for efficient protein delivery via extracellular vesicles},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {10},
  pages = {e0310083},
  doi = {10.1371/journal.pone.0310083}
}
Kostenlos starten →